Listing ID #5641090
Company Information
Ask for more detail from the seller
Contact SupplierSorafenib, is a kinase inhibitor drug approved for the treatment of primary kidney cancer, advanced primary liver cancer, FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma.